A new study finds a long-acting medication and a short-term drug that must be taken daily are equally effective in treating opioid addiction.
Researchers at NYU Langone Health found extended-release naltrexone (Vivitrol) was as safe and effective as more commonly prescribed buprenorphine-naloxone (Suboxone) in curtailing opioid use, relapse, treatment drop-out, and overdose.
The study, which was sponsored by the National Institute on Drug Abuse, was published in The Lancet.
The study is the first major head-to-head comparison of the treatments, according to The Washington Post. Researchers found each treatment had disadvantages. Short-acting medicines must be taken daily for years or even a lifetime...Read more